Use of a MT kinase inhibitor for treating or preventing brain cancer

Details for Australian Patent Application No. 2007310842 (hide)

Owner Janssen Pharmaceutica NV

Inventors Janicot, Michel Marie Francois; Page, Martin John; Freyne, Eddy Jean Edgard; Perera, Timothy Pietro Suren

Agent Shelston IP

Pub. Number AU-A-2007310842

PCT Pub. Number WO2008/049901

Priority 60/863,162 27.10.06 US; 60/976,168 28.09.07 US; 06123058.7 27.10.06 EP

Filing date 25 October 2007

Wipo publication date 2 May 2008

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

4 June 2009 PCT application entered the National Phase

  PCT publication WO2008/049901 Priority application(s): WO2008/049901

28 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007310843-Macrocyclic quinazoline derivatives as VEGFR3 inhibitors

2007310838-Intranasal delivery of polypeptides and proteins